Showing 381-390 of 5790 results for "".
Janssen Approvals, New Thermage FLX, Restylane Silk Cannulas
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-janssen-approvals-new-thermage-flx-restylane-silk-cannulas/18401/Janssen Biotech's Stelara is now approved for the treatment of adolescents 12 years of age or older with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy. Janssen's SIMPONI ARIA® cleared for the treatment of adults with active psoriatic arthritis or activeNew Treatment Algorithms for Actinic Keratoses
https://practicaldermatology.com/topics/skin-cancer-photoprotection/new-treatment-algorithms-for-actinic-keratoses/18812/Gary Goldenberg, MD reviews the literature showing why all actinic keratoses (AKs) need to be treated and why it's important to treat the field and not just the visible lesions. He shares his evidence-based, time-sequential therapy approach to combining a destructive modality with field therapy to pAdvances in Treating NMSC
https://practicaldermatology.com/topics/skin-cancer-photoprotection/advances-in-treating-nmsc/18742/Dr. Goldenberg discusses the benefits of timed sequential therapy using two modalities — destructive therapy followed by field therapy — for actinic keratoses. He also talks about treatment options for advanced basal cell carcinoma, squamous cell carcinoma, and merkel cell carcinoma.Science of Skincare Summit 2024: On the FDA Approval of Emrosi for Rosacea
https://practicaldermatology.com/conferences/science-skincare-summit-2024/science-of-skincare-summit-2024-on-the-fda-approval-of-emrosi-for-rosacea/29276/At the Science of Skincare Summit in Austin, Practical Dermatology caught up with Chief Medical Editor Neal Bhatia, MD, and James Del Rosso, DO, a dermatologist and Editor in Chief of Clinical Dermatology at the Journal of Clinical and Aesthetic Dermatology (JCAD), who shared insights and thoughts oEssential Marketing Strategies
https://practicaldermatology.com/topics/practice-management/essential-marketing-strategies/18436/There are three essential tactics that set successful marketers apart from the rest. Risa Goldman Luksa of Goldman Marketing Group explains.Standing Apart: The Personal Touch
https://practicaldermatology.com/topics/practice-management/standing-apart-the-personal-touch/18437/Many dermatology practices exist in a crowded market place. How can they set themselves apart? Focus on the personal touch, says Gary Goldenberg, MD of Goldenberg Dermatology.DermWireTV Extra: Lubriderm Launches Skin Scholarship with the NHHF
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-extra-lubriderm-launches-skin-scholarship-with-the-nhhf/20060/Suzanne Goldstein, Senior Director of Marketing for Lubriderm, explains the Skin Scholarship sponsored by Lubriderm and created in partnership with the National Hispanic Health Foundation (NHHF). This scholarship program aims to increase representation and accessibility within the field.Four Gen Z trends that dermatology practices should know
https://practicaldermatology.com/topics/practice-management/four-gen-z-trends-that-dermatology-practices-should-know/20007/As Generation Z continues to mature, their behaviors as consumers will increasingly guide how practices and other organizations appeal to them. Why not get a jumpstart? At Ekwa Marketing, we got into the heads of a generation that is increasingly exerting its influence on household buying decisionsFive ways to promote new treatments
https://practicaldermatology.com/topics/practice-management/five-ways-to-promote-new-treatments/20001/The dermatology device market is booming. It takes particular skills to distinguish between those innovative technologies that provide a great value to your patients and those that are less about substance and more about sexy marketing. Likewise, your current patients and “lurkers” on your social meDermWireTV: COVID-19 Loans, Taltz for Peds, Finacea Returns
https://practicaldermatology.com/topics/practice-management/dermwiretv-covid-19-loans-taltz-for-peds-finacea-returns/19808/SBA Loans and Paycheck Protection Program (PPP) loans for practices impacted by the coronavirus pandemic are among the options addressed in a new video series, “Coping with COVID-19.” Eli Lilly and Company's Taltz is now approved to manage moderate to severe plaque psoriasis in pediatric patients a